169 related articles for article (PubMed ID: 17209294)
21. The socioeconomic costs of mental illness in Spain.
Oliva-Moreno J; López-Bastida J; Montejo-González AL; Osuna-Guerrero R; Duque-González B
Eur J Health Econ; 2009 Oct; 10(4):361-9. PubMed ID: 19031056
[TBL] [Abstract][Full Text] [Related]
22. Cost of dementia in the pre-enlargement countries of the European Union.
Luengo-Fernandez R; Leal J; Gray AM
J Alzheimers Dis; 2011; 27(1):187-96. PubMed ID: 21860095
[TBL] [Abstract][Full Text] [Related]
23. The cost of mental disorders in France.
Chevreul K; Prigent A; Bourmaud A; Leboyer M; Durand-Zaleski I
Eur Neuropsychopharmacol; 2013 Aug; 23(8):879-86. PubMed ID: 22959739
[TBL] [Abstract][Full Text] [Related]
24. [Cost of disorders of the brain in Austria in the year 2004].
Wancata J; Sobocki P; Katschnig H;
Wien Klin Wochenschr; 2007; 119(3-4):91-8. PubMed ID: 17347857
[TBL] [Abstract][Full Text] [Related]
25. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
26. Cost of disorders of the brain in Spain.
Parés-Badell O; Barbaglia G; Jerinic P; Gustavsson A; Salvador-Carulla L; Alonso J
PLoS One; 2014; 9(8):e105471. PubMed ID: 25133395
[TBL] [Abstract][Full Text] [Related]
27. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
28. Economic costs of social phobia: a population-based study.
Acarturk C; Smit F; de Graaf R; van Straten A; Ten Have M; Cuijpers P
J Affect Disord; 2009 Jun; 115(3):421-9. PubMed ID: 19012968
[TBL] [Abstract][Full Text] [Related]
29. The size and burden of mental disorders and other disorders of the brain in Europe 2010.
Wittchen HU; Jacobi F; Rehm J; Gustavsson A; Svensson M; Jönsson B; Olesen J; Allgulander C; Alonso J; Faravelli C; Fratiglioni L; Jennum P; Lieb R; Maercker A; van Os J; Preisig M; Salvador-Carulla L; Simon R; Steinhausen HC
Eur Neuropsychopharmacol; 2011 Sep; 21(9):655-79. PubMed ID: 21896369
[TBL] [Abstract][Full Text] [Related]
30. The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.
Maercker A; Perkonigg A; Preisig M; Schaller K; Weller M;
Swiss Med Wkly; 2013; 143():w13751. PubMed ID: 23297120
[TBL] [Abstract][Full Text] [Related]
31. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
32. Cost of disorders of the brain in Norway.
Stovner LJ; Gjerstad L; Gilhus NE; Storstein A; Zwart JA
Acta Neurol Scand Suppl; 2010; (190):1-5. PubMed ID: 20586727
[TBL] [Abstract][Full Text] [Related]
33. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
34. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.
Wimo A; Jönsson L; Gustavsson A; McDaid D; Ersek K; Georges J; Gulácsi L; Karpati K; Kenigsberg P; Valtonen H
Int J Geriatr Psychiatry; 2011 Aug; 26(8):825-32. PubMed ID: 21744385
[TBL] [Abstract][Full Text] [Related]
35. Societal cost of skin cancer in Sweden in 2005.
Tinghög G; Carlsson P; Synnerstad I; Rosdahl I
Acta Derm Venereol; 2008; 88(5):467-73. PubMed ID: 18779884
[TBL] [Abstract][Full Text] [Related]
36. [The cost of illness].
van Roijen L; Koopmanschap MA; Bonneux L
Ned Tijdschr Geneeskd; 1992 Jan; 136(2):74-80. PubMed ID: 1732831
[TBL] [Abstract][Full Text] [Related]
37. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
38. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
39. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
40. Consensus document on European brain research.
Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
